Osteocalcin and bone remodelling in Paget's disease of bone, primary hyperparathyroidism, hypercalcaemia of malignancy and involutional osteoporosis

References

• Krane S, Muñoz A J, Harris F D. Urinary polypeptides related to collagen synthesis. J Clin Invest 1970; 49: 716–20
   PubMed Web of Science ®Google Scholar
• Posen S, Cornish C, Klecrekoper M. Alkaline phosphatase and metabolic disorders. Metabolic Bone Disease, L V Avioli, S M Krane. Academic Press, New York 1977; 1: 141–52
   Google Scholar
• Delmas P D, Malaval L. New biochemical markers of bone turnover. Calcium regulation and bone metabolism: Basic and clinical aspects, D V Colin, T J Martin, P J Meunier. Excerpla Medi-ca, Amsterdam, New York, Oxford 1987; vol. 9: 105–12
   Google Scholar
• Mundy G R. Bone resorption and turnover in health and disease. Bone 1987; 8(Suppl. 1)S9–S16
   Google Scholar
• Lowry O H, Roberts N R, Meilinge W V, Hixon W S, Crawford E J. The quantitative histochemistry of brain Enzyme measurements. J Biol Chem 1954; 207: 19–37
   PubMed Web of Science ®Google Scholar
• Henry R J. Quimica clinica. Bases y principios Barcelons. JIMS 1969; 1: 347–65
   Google Scholar
• Kivirikko K I, Laitinen Prokop O. D.J. Modifications of a specific assay for hydroxvproline in urine. Anal Biochem 1967; 19: 249–55
   PubMed Web of Science ®Google Scholar
• Piedra C, de la, Toural V, Rapado A. Osteocalcin and urinary hydroxyprolinc/creatinine ratio in the differential diagnosis of primary hyperparathyroidism and hypercalcaemia of malignancy. Scand J Clin Lab Invest 1987; 47: 587–92
   Google Scholar
• Riggs B L, Mann K G. Assessment of metabolic bone diseases by measurement of serum hone Gla-protein. Development and diseases of cartilage and bone matrix, A Sen, T Thornhill. Alan R Liss lnc, New York 1987; 177–86
   Google Scholar
• Price P A, Parthemore J G, Deftos L J, Nishimoto S K. New biochemical marker for bone metabolism. Measurement by RIA of bone Gla protein in the plasma of normal subjects and patients with bone disease. J Clin Invest 1980; 66: 878–83
   PubMed Web of Science ®Google Scholar
• Deftos L J, Parthemore J G, Price P A. Changes in plasma bone Gla-protein during treatment of bone disease. Calcif Tissue Int 1982; 34: 121–4
   PubMed Web of Science ®Google Scholar
• Gundberg C M, Lian I B, Gallop P M, Steinberg J J. Urinary carboxyglutamic acid and serum osteocalcin as bone markers: studies in osteoporosis and Paget's disease. J Clin Endocrinol Metab 1983; 57: 1221–5
   PubMed Web of Science ®Google Scholar
• Delmas P D, Demiaux B, Malaval L, Chapuy M C, Meunier P J. Serum bone Gla-protein is not a sensitive marker of bone turnover in Paget's disease of bone. Calcif Tissue lnt 1986; 38: 60–1
   PubMed Web of Science ®Google Scholar
• Papapoulos S E, Frohlich M, Mudde A H, Harnick H IJ, Berg H, Bijvoet O LM. Serum osteocalcin in Paget's disease of bone: basal concentrations and response to biphosphonate treatment. J Clin Endocrinol Metab 1987; 65: 89–94
   Google Scholar
• Wilkinson M R, Wagstaffe C, Delbridge L, Wiseman J, Posen S. Serum osteocalcin concentrations in Paget's disease of bone. Arch Intern Med 1986; 146: 268–71
   Google Scholar
• Rico H, Cabranes J A, Almoguera I, Hernandez E R, Arroyo M. Osteocalcina en la enfermedad osea de Paget: evidencia de su reutilizacion en la nueva ostcoformacion. Med Clin (Bare) 1987; 88: 13–5
   Google Scholar
• Gundberg C, Aronoff J, Gallop P. The clinical usefulness of serum osteocalcin measurements. The Chemistry and biology of mineralized tissues, W T Butler. EBSCO Media, Birmingham 1985; 411–5
   Google Scholar
• Piedra C, de la, Rapado A, Esbrit P. Niveles sericos de osteocalcina en la hipercalcemia del hiperparatiroidismo primario y en la hipercalcemia tumoral. Rev Clin Esp 1985; 117: 310–3
   Google Scholar
• Delmas P D, Demiaux B, Malaval L, Chapuy M C, Edouard C, Meunier P J. Serum bone gamma carboxyglutamic acid-containing protein in primary hyperparathyroidism and in malignant hypercalcemia. J Clin Invest 1986; 77: 985–91
   PubMed Web of Science ®Google Scholar
• Slovick D M, Gundberg C M, Neer R M, Lian J B. Clinical evaluation of bone turnover by serum osteocalcin measurements in a hospital setting. J Clin Endocrinol Metab 1984; 59: 228–50
   Google Scholar
• Yasumura S, Aloia J F, Gundberg C M, et al. Serum osteocalcin and total body calcium in normal pre- and postmenopausal women and postmenopausal osteoporotic patients. J Clin Endocrinol Metab 1987; 64: 681–5
   PubMedGoogle Scholar
• Canniggia A, Nuti R, Galli M, Loré F, Turchetti V, Righi G A. Effect of a long-term treatment with 1,25-dihydroxyvitamin D, on osteocalcin in postmenopausal osteoporosis. Calcif Tissue Int 1986; 38: 328–32
   Google Scholar
• Ismail F, Epstein S, Pacifici R, Drokc D, Thomas S B, Avioli L V. Serum bone Gla protein (BGP) and other markers of bone mineral metabolism in postmenopausal osteoporosis. Calcif Tissue Int 1986; 39: 230–3
   PubMed Web of Science ®Google Scholar
• Delmas P D, Brown J P, Malaval L, Edouard C, Meunier P J. Serum bone Gla-protein (BGP) compared to bone histomorphometry in postmenopausal osteoporosis: serum BGP can predict histological heterogeneity. Endocrine Control of Bone and Calcium Metabolism, D V Cohn, T Fujita, J T Potts, Jr, R V Talmage. Excerpta Medica, Amsterdam 1984; 73–7
   Google Scholar
• Brown J P, Malaval L, Chapuy M C, Delmas P D, Edouard C, Meunier P J. Serum bone Gla-protein: a specific marker for bone formation in postmenopausal osteoporosis. Lancet 1984; 19: 1091–3
   Google Scholar
• Stracke H, Schulz A, Weber U, Ullmann J, Schatz H. Osteocalcin and bone histomorphometry in osteoporosis. Klin Wochcnschr 1987; 65: 1095–100
   Google Scholar
• Riggs B L, Melton L J, III. Involutional osteoporosis. N Engl J Med 1986; 26: 1676–86
   Google Scholar
• Stewart A F, Vignery A, Silvcrglate A, et al. Quantitative bone histomorphometry in humoral hypercalcemia of malignancy: Uncoupling of bone cell activity. J Clin Endocrinol Metab 1982; 55: 219–27
   PubMed Web of Science ®Google Scholar
• Blomquist C, Elomaa I, Virkkunen P, et al. The response evaluation of bone metastases in mammary carcinoma. Cancer 1987; 60: 2907–12
   Google Scholar
• Ivey J L, Baylink D J. Postmenopausal osteoporosis: proposed roles of defective coupling and estrogen deficiency. Metab Bone Dis & Rel Res 1981; 3: 3–7
   PubMedGoogle Scholar